Page 122 - Read Online

Alipov et al. Difference between native and desialylated LDL

64. Estruch M, Sanchez-Quesada JL, Beloki L, Ordoñez-Llanos J, Benitez 76. Tertov VV, Sobenin IA, Kaplun VV, Orekhov AN. Antioxidant
S. The induction of cytokine release in monocytes by electronegative content in low density lipoprotein and lipoprotein oxidation in vivo
low-density lipoprotein (LDL) is related to its higher ceramide content and in vitro. Free Radic Res 1998;29:165-73.
than native LDL. Int J Mol Sci 2013;14:2601-16. 77. Oztürk Z, Sönmez H, Görgün FM, Ekmekçi H, Bilgen D, Ozen
65. Ke LY, Stancel N, Bair H, Chen CH. The underlying chemistry N, Sözer V, Altuğ T, Kökoğlu E. The relationship between lipid
of electronegative LDL’s atherogenicity. Curr Atheroscler Rep peroxidation and LDL desialylation in experimental atherosclerosis.
2014;16:428. Toxicol Mech Methods 2007;17:265-73.
66. Sánchez-Quesada JL, Pérez A. Modified lipoproteins as biomarkers 78. Tertov VV, Kaplun VV, Sobenin IA, Boytsova EY, Bovin NV, Orekhov
of cardiovascular risk in diabetes mellitus. Endocrinol Nutr AN. Human plasma trans-sialidase causes atherogenic modification of
2013;60:518-28. low density lipoprotein. Atherosclerosis 2001;159:103-15.
67. Younis NN, Soran H, Pemberton P, Charlton-Menys V, Elseweidy 79. Mahajan VS, Pillai S. Sialic acids and autoimmune disease. Immunol
MM, Durrington PN. Small dense LDL is more susceptible to Rev 2016;269:145-61.
glycation than more buoyant LDL in Type 2 diabetes. Clin Sci (Lond) 80. Macauley MS, Crocker PR, Paulson JC. Siglec-mediated regulation of
2013;124:343-9. immune cell function in disease. Nat Rev Immunol 2014;14:653-66.
68. Del Turco S, Basta G. An update on advanced glycation endproducts 81. Hutzler S, Özgör L, Naito-Matsui Y, Kläsener K, Winkler TH, Reth
and atherosclerosis. Biofactors 2012;38:266-74. M, Nitschke L. The ligand-binding domain of Siglec-G is crucial for its
69. Grewal T, Bartlett A, Burgess JW, Packer NH, Stanley KK. selective inhibitory function on B1 cells. J Immunol 2014;192:5406-14.
Desialylated LDL uptake in human and mouse macrophages can be 82. O’Neill AS, van den Berg TK, Mullen GE. Sialoadhesin - a
mediated by a lectin receptor. Atherosclerosis 1996;121:151-63. macrophage-restricted marker of immunoregulation and inflammation.
70. Bhakdi S, Dorweiler B, Kirchmann R, Torzewski J, Weise E, Tranum- Immunology 2013;138:198-207.
Jensen J, Walev I, Wieland E. On the pathogenesis of atherosclerosis: 83. Sobenin IA, Salonen JT, Zhelankin AV, Melnichenko AA, Kaikkonen
enzymatic transformation of human low density lipoprotein to an J, Bobryshev YV, Orekhov AN. Low density lipoprotein-containing
atherogenic moiety. J Exp Med 1995;182:1959-71. circulating immune complexes: role in atherosclerosis and diagnostic
71. Klouche M, Gottschling S, Gerl V, Hell W, Husmann M, Dorweiler value. Biomed Res Int 2014;2014:205697.
B, Messner M, Bhakdi S. Atherogenic properties of enzymatically 84. Burut DF, Karim Y, Ferns GA. The role of immune complexes in
degraded LDL: selective induction of MCP-1 and cytotoxic effects on atherogenesis. Angiology 2010;61:679-89.
human macrophages. Arterioscler Thromb Vasc Biol 1998;18:1376-85. 85. Montano EN, Boullier A, Almazan F, Binder CJ, Witztum JL,
72. Klouche M, May AE, Hemmes M, Messner M, Kanse SM, Hartvigsen K. Development and application of a nonradioactive
Preissner KT, Bhakdi S. Enzymatically modified, nonoxidized binding assay of oxidized low-density lipoprotein to macrophage
LDL induces selective adhesion and transmigration of monocytes scavenger receptors. J Lipid Res 2013;54:3206-14.
and T-lymphocytes through human endothelial cell monolayers. 86. Tertov VV, Sobenin IA, Orekhov AN, Jaakkola O, Solakivi T, Nikkari
Arterioscler Thromb Vasc Biol 1999;19:784-93. T. Characteristics of low density lipoprotein isolated from circulating
73. Tertov VV, Sobenin IA, Gabbasov ZA, Popov EG, Jaakkola O, immune complexes. Atherosclerosis 1996;122:191-9.
Solakivi T, Nikkari T, Smirnov VN, Orekhov AN. Multiple-modified 87. Schultze HE, Heide K. Carbohydrate content of different blood
desialylated low density lipoproteins that cause intracellular lipid components. Med Grundlogenforsch 1960;3:357.
accumulation. Isolation, fractionation and characterization. Lab Invest 88. Ayrault-Jarrier M. Action des detergents sur une β-lipoproteine
1992;67:665-75. lumaine isoleé: etude de l’extractibilité des lipids. Bull Soc Chim Biol
74. Dousset N, Dousset JC, Taus M, Ferretti G, Curatola G, Soléra ML, (Paris) 1961;43:153-65. (in French)
Valdiguié P. Effect of desialylation on low density lipoproteins: 89. Marshall WE, Kummerow FA. The carbohydrate constituents of
comparative study before and after oxidative stress. Biochem Mol Biol human serum-lipoprotein: galactose, mannose, glucosamine, and
Int 1994;32:555-63. sialic acid. Arch Biochem Biophys 1962;98:271-3.
75. Barbosa DS, Maranhão RC, Araújo FB, Chang YH, Hirata MH, Abdalla 90. Kwiterovich P, Bachorik P, Simon A. Isolation and partial
DS. Sialic acid and oxidizability of low density lipoprotein subfractions characterization of the glycopeptides from human plasma low density
of hyperlipidemic patients. Clin Biochem 1995;28:435-41. lipoproteins. Circ Suppl III 1974;49-50:267.

Vessel Plus ¦ Volume 1 ¦ September 26, 2017 115